10:40 AM EST - Avant Technologies Inc : Announced a newly published study from the Mayo Clinic reinforces the critical role of the “longevity protein” a-Klotho in vascular health and aging. The research, appearing in the Journal of the American Heart Association, demonstrates a strong association between declining a-Klotho levels and arterial stiffness, endothelial dysfunction, vascular calcification, and significantly reduced patient survival. Avant Technologies Inc
shares O.AVAI are trading unchanged at $0.29.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=7534197575304977
